Ep5: The Future of Weight Loss in Telemedicine: Navigating the FDA Shakeup

This episode is sponsored by: Set For LifeSet for Life Insurance helps doctors safeguard their future with True Own Occupational Disability Insurance. A single injury or illness can change everything, but the best physicians plan ahead. Protect your income and secure your future before life makes the choice for you. Your career deserves protection—act now at https://www.doctorpodcastnetwork.co/setforlife_________Recent FDA changes have rocked the telemedicine industry, specifically affecting providers and patients who rely on GLP-1 medications for weight loss. As tirzepatide and semaglutide are removed from the shortage list, compounding pharmacies will soon lose the ability to produce affordable alternatives. This shift has major implications for physicians, telehealth companies, and millions of patients.Dr. Leo Damasco and Phoebe Gutierrez break down the regulatory landscape, explain why Big Pharma plays a key role in these changes, and discuss what providers should do next. They discuss the financial impact on telemedicine startups, the likelihood of legal challenges, and strategies for doctors to pivot before revenue streams dry up.If you're a physician in telemedicine, a healthcare entrepreneur, or a patient relying on compounded GLP-1 medications, this episode is a must-listen.Three Actionable Takeaways:Prepare for Industry Changes – The removal of GLP-1 medications from the shortage list means providers and companies must pivot quickly. Consider alternative treatment models like health coaching and integrative medicine.Expect Patient Backlash – With compounded GLP-1 medications becoming unavailable, patients will see costs skyrocket. Physicians should prepare for difficult conversations and set clear expectations.Diversify Revenue Streams – Telehealth companies that rely solely on weight loss treatments may not survive this shift. Physicians should explore new specialties or services to ensure financial stability.About the Show:Telemedicine Talks explores the evolving world of digital health, helping physicians navigate new opportunities, regulatory challenges, and career transitions in telemedicine.About the Hosts:🔹 Dr. Leo Damasco – A pediatrician and emergency medicine doctor who transitioned into telemedicine, finding flexibility and new opportunities along the way.🔹 Phoebe Gutierrez – Former state regulator turned startup executive, now helping companies and physicians build smarter, compliant, and sustainable telemedicine businesses.Connect with Phoebe Gutierrez:LinkedIn: linkedin.com/in/pkgutierrezEmail: [email protected] Telemedicine, Digital Health, Physician Careers, Medical Regulations, Virtual Care, Weight Loss, GLP-1 Medications, FDA Regulations, Telehealth Startups The information provided in Telemedicine Talks is for educational and informational purposes only and should not be construed as medical, legal, or financial advice. While we discuss best practices, industry trends, and real-world experiences, every situation is unique. Listeners should consult with qualified professionals before making decisions related to telemedicine practice, compliance, contracts, or business operations. The views expressed by the hosts and guests are their own and do not necessarily reflect those of any organizations they may be affiliated with. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.